David Seiffge Selected Research

Acenocoumarol

1/2021

Aspirin versus anticoagulation in cervical artery dissection (TREAT-CAD): an open-label, randomised, non-inferiority trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David Seiffge Research Topics

Disease

18	Stroke (Strokes) 01/2024 - 05/2015
15	Ischemic Stroke 04/2024 - 10/2020
5	Hemorrhage 04/2024 - 01/2018
5	Cerebral Hemorrhage 03/2024 - 01/2016
5	Transient Ischemic Attack 12/2023 - 01/2022
4	Atrial Fibrillation 12/2023 - 08/2021
4	Neoplasms (Cancer) 01/2023 - 07/2022
3	Infarction (Infarctions) 03/2024 - 07/2010
3	Hematoma 03/2024 - 09/2022
2	Blood Vessel Dissection 02/2024 - 01/2021
2	Intracranial Hemorrhages (Intracranial Hemorrhage) 12/2023 - 01/2023
2	Cerebral Small Vessel Diseases 09/2022 - 01/2022
1	Traumatic Cerebral Hemorrhage 03/2024
1	Ischemia 02/2024
1	Hypertension (High Blood Pressure) 12/2023
1	Coronary Disease (Coronary Heart Disease) 12/2023
1	Intracranial Arteriosclerosis (Cerebral Atherosclerosis) 01/2023
1	Diabetes Mellitus 01/2023
1	Embolism (Embolus) 01/2023
1	Siderosis 01/2023
1	Atherosclerosis 01/2023
1	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 09/2022
1	Brain Ischemia (Cerebral Ischemia) 09/2022
1	Embolic Stroke 08/2022
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2022
1	Epilepsy (Aura) 08/2021
1	Wounds and Injuries (Trauma) 01/2018
1	Arterial Occlusive Diseases (Arterial Occlusive Disease) 05/2015
1	Pathologic Constriction (Stenosis) 05/2015
1	Cerebral Infarction 07/2010

Drug/Important Bio-Agent (IBA)

10	AnticoagulantsIBA 02/2024 - 08/2021
7	Biomarkers (Surrogate Marker)IBA 10/2023 - 01/2022
4	Warfarin (Coumadin)FDA LinkGeneric 10/2023 - 01/2021
4	Vitamin K FDA Link 10/2023 - 01/2021
3	fibrin fragment D (D-dimer)IBA 01/2023 - 01/2022
2	PRT064445IBA 03/2024 - 10/2023
2	Factor Xa InhibitorsIBA 03/2024 - 10/2023
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 02/2024 - 01/2021
2	A-factor (Streptomyces)IBA 10/2023 - 07/2010
2	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2023 - 01/2023
2	C-Reactive ProteinIBA 09/2022 - 01/2022
2	Glucose (Dextrose)FDA LinkGeneric 07/2022 - 05/2015
2	Tranexamic Acid (AMCA)FDA Link 01/2018 - 01/2016
1	thiamine triphosphorate (TTP)IBA 03/2024
1	N(4)-methyl-2'-deoxycytidine 5'-triphosphateIBA 03/2024
1	N(4)-oleylcytosine arabinosideIBA 03/2024
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2023
1	LipidsIBA 12/2023
1	RivaroxabanIBA 10/2023
1	Blood Coagulation Factors (Coagulation Factor)IBA 10/2023
1	Factor IIaIBA 10/2023
1	AntidotesIBA 10/2023
1	apixabanIBA 10/2023
1	Prothrombin (Factor II)IBA 10/2023
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2023
1	APTIBA 01/2023
1	Oral ContraceptivesIBA 01/2023
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 01/2023
1	Hemoglobins (Hemoglobin)IBA 01/2023
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2023
1	Apolipoproteins E (ApoE)IBA 09/2022
1	CreatinineIBA 07/2022
1	pro-brain natriuretic peptide (1-76)IBA 01/2022
1	TroponinIBA 01/2022
1	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2022
1	Dabigatran FDA Link 01/2022
1	Phenprocoumon (Liquamar)FDA Link 01/2021
1	AcenocoumarolIBA 01/2021
1	SodiumIBA 07/2010
1	ChlorineIBA 07/2010
1	Protons (Proton)IBA 07/2010

Therapy/Procedure

11	Therapeutics 04/2024 - 08/2021
8	Thrombectomy 01/2024 - 10/2020
2	Secondary Prevention 01/2023 - 01/2023
1	Treatment Delay 02/2024
1	Conservative Treatment 02/2024
1	Time-to-Treatment 01/2024
1	Glycemic Control 01/2023
1	Neurological Rehabilitation 08/2021